In vitro Antibacterial Activity of Doripenem against Gram-Negative Blood Isolates in a Korean Tertiary Care Center

BACKGROUND: Doripenem is the most recently introduced antimicrobial agent of the carbapenem class. It is a valuable therapeutic option in the context of increasing antimicrobial resistance to imipenem and meropenem among gram-negative bacilli (GNB) clinical isolates. However, clinicians are usually...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seong-Ho, Ahn, Mi Young, Chung, Jin-Won, Lee, Mi-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607770/
https://www.ncbi.nlm.nih.gov/pubmed/26483991
http://dx.doi.org/10.3947/ic.2015.47.3.175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607770/
https://www.ncbi.nlm.nih.gov/pubmed/26483991
http://dx.doi.org/10.3947/ic.2015.47.3.175

Ejemplares similares